EX-23.1 4 ex23-1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-1 of Bone Biologics Corporation of our report dated March 30, 2023, (which report includes an explanatory paragraph regarding the Company’s ability to continue as a going concern) with respect to the consolidated financial statements of Bone Biologics Corporation as of December 31, 2022 and 2021, and for the years then ended, included in Bone Biologics Corporation’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission. We also consent to the reference to our firm under the caption “Experts” in such Registration Statement.

 

/s/Weinberg and Company, P.A.

Los Angeles, California

May 1, 2023